AAAAAA

   
Results: 1-13 |
Results: 13

Authors: SERKKOLA E AHO P NISSINEN E
Citation: E. Serkkola et al., INHIBITION OF LPS-INDUCED CYTOKINE PRODUCTION IN MONONUCLEAR-CELLS BYORAZIPONE (OR-1384), European cytokine network, 9(3), 1998, pp. 239-239

Authors: NISSINEN E KAIVOLA J LINDEN IB
Citation: E. Nissinen et al., INHIBITION OF NEUTROPHIL ACTIVATION BY A NOVEL THIOL MODULATING COMPOUND OR-1384, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 2318-2318

Authors: VENTO AE RAMO OJ NEMLANDER AT NISSINEN E HOLOPAINEN A MATTILA SP
Citation: Ae. Vento et al., NITECAPONE IS OF BENEFIT TO FUNCTIONAL PERFORMANCE IN EXPERIMENTAL HEART-TRANSPLANTATION, Research in experimental medicine, 197(3), 1997, pp. 137-146

Authors: KAAKKOLA S NISSINEN E TERAVAINEN H
Citation: S. Kaakkola et al., DETERMINATION OF M-O-METHYLATED AND P-O-METHYLATED PRODUCTS OF LEVODOPA AND COMT ACTIVITY IN PARKINSONS-DISEASE, Journal of neurochemistry, 69, 1997, pp. 174-174

Authors: NISSINEN E SERKKOLA E PENTTILA KE KAIVOLA J AHO P LINDEN IB
Citation: E. Nissinen et al., SUPPRESSION OF CYTOKINE PRODUCTION AND NEUTROPHIL ACTIVATION BY AN IMMUNOMODULATING AGENT OR-1384, Gastroenterology, 112(4), 1997, pp. 1051-1051

Authors: NISSINEN E KAHEINEN P PENTTILA KE KAIVOLA J LINDEN IB
Citation: E. Nissinen et al., ENTACAPONE, A NOVEL CATECHOL-O-METHYLTRANSFERASE INHIBITOR FOR PARKINSONS-DISEASE, DOES NOT IMPAIR MITOCHONDRIAL ENERGY-PRODUCTION, European journal of pharmacology, 340(2-3), 1997, pp. 287-294

Authors: NISSINEN E LINDEN IB POHTO P
Citation: E. Nissinen et al., ANTIOXIDANT PROPERTIES OF NITECAPONE ARE POTENTIATED BY GLUTATHIONE, Biochemistry and molecular biology international, 35(2), 1995, pp. 387-395

Authors: HAIKALA H NISSINEN E ETEMADZADEH E LEVIJOKI J LINDEN IB
Citation: H. Haikala et al., TROPONIN C-MEDIATED CALCIUM SENSITIZATION INDUCED BY LEVOSIMENDAN DOES NOT IMPAIR RELAXATION, Journal of cardiovascular pharmacology, 25(5), 1995, pp. 794-801

Authors: HAIKALA H KAIVOLA J NISSINEN E WALL P LEVIJOKI J LINDEN IB
Citation: H. Haikala et al., CARDIAC TROPONIN-C AS A TARGET PROTEIN FOR A NOVEL CALCIUM SENSITIZING DRUG, LEVOSIMENDAN, Journal of Molecular and Cellular Cardiology, 27(9), 1995, pp. 1859-1866

Authors: POLLESELLO P OVASKA M KAIVOLA J TILGMANN C LUNDSTROM K KALKKINEN N ULMANEN I NISSINEN E TASKINEN J
Citation: P. Pollesello et al., BINDING OF A NEW CA2-C - A MOLECULAR MODELING, FLUORESCENCE PROBE, AND PROTON MAGNETIC-RESONANCE STUDY (VOL 269, PG 28584, 1994)( SENSITIZER, LEVOSIMENDAN, TO RECOMBINANT HUMAN CARDIAC TROPONIN), The Journal of biological chemistry, 270(6), 1995, pp. 2880-2880

Authors: POLLESELLO P OVASKA M KAIVOLA J TILGMANN C LUNDSTROM K KALKKINEN N ULMANEN I NISSINEN E TASKINEN J
Citation: P. Pollesello et al., BINDING OF A NEW CA2-C - A MOLECULAR MODELING, FLUORESCENCE PROBE, AND PROTON NUCLEAR-MAGNETIC-RESONANCE STUDY( SENSITIZER, LEVOSIMENDAN, TO RECOMBINANT HUMAN CARDIAC TROPONIN), The Journal of biological chemistry, 269(46), 1994, pp. 28584-28590

Authors: NISSINEN E LAULAJAINEN T HOLOPAINEN A KAIVOLA J AHO P LINDEN IB
Citation: E. Nissinen et al., SUPPRESSION OF NEUTROPHIL AND T-LYMPHOCYTE ACTIVATION BY AN ANTICOLITIS AGENT OR-1364, Gastroenterology, 106(4), 1994, pp. 10000745-10000745

Authors: AHO P NISSINEN E PENTTILA K HAASIO K LINDEN IB
Citation: P. Aho et al., THE SULFHYDRYL MODULATING COMPOUND OR-1364 PROTECTS AGAINST FREE-RADICAL INDUCED COLITIS IN RATS, Gastroenterology, 104(4), 1993, pp. 659-659
Risultati: 1-13 |